Chemical precursors, the unknown dimension of the world’s illegal drug market
Drugs, International Challenges n° 7, OFDT, 7 p.
Precursor trafficking draws little attention as efforts are focused on seizures of finished products listed as narcotics. Yet, this trafficking is a reality that now touches all continents and makes use of all major global trade routes. For the services responsible for controlling chemical precursors and preventing their trafficking, the task is extremely complex because, in contrast with finished products, the production and commerce of substances involved in the production of the majority of illegal drugs is in fact perfectly legal. Furthermore, to circumvent the controls established by international conventions and regulations, dealers constantly adapt by using unclassified substances. After presenting an overview in the first section of the global situation, and in particular, the main trafficking routes, this issue will discuss the latest trends, and especially the challenges facing Europe with the appearance on the market of new precursors and pre-precursors. The third section will be dedicated to the resources employed by the international community to fight against this phenomenon.
Author: Michel Gandilhon
Download the PDF file (3,27 Mo)
Drugs in Europe
- Drug facts, figures and analyses: across Europe and by country
- Latest trends and legal, political and social responses
- Selected issues: Vulnerable groups of young people; National drug-related research in Europe; Towards a better understanding of drug-related public expenditure in Europe
Country situation summaries
The European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) website has a concise overview for each EU Member State on their national drug situation, as well as legal texts in their original formats, an indispensable tool for monitoring and analysing legislative developments in the Member States.
The European Union and the drug phenomenon
The European Union & the drug phenomenon : Frequently asked questions , joint publication between the EMCDDA and the European Commission, october 2010, 12 p.